MELINTA THERAPEUTICS, LLC
MORRISTOWN, NEW JERSEY 079604558
Top Industries (NAICS)
| NAICS Code | Obligations | Awards |
|---|---|---|
| 541714 | $47.52M | 6 |
| 325412 | $0 | 25 |
Contract Awards
5 awards found
THE PURPOSE OF THIS MODIFICATION IS TO IS EXERCISE AND FULLY FUND CLIN0002/OPTION 1
THE PURPOSE OF THIS MODIFICATION IS TO IS EXERCISE AND FULLY FUND OPTION 5/CLIN0004, PROVIDE SUPPLEMENTAL FUNDING FOR CLIN0001 AND CLIN0003, REVISE THE BUDGET AND PERIOD OF PERFORMANCE FOR CLIN0006, AND UPDATE THE STATEMENT OF WORK.
EXERCISE CLIN 0004 OPTION
ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN
ADVANCE THE DEVELOPMENT OF TWO ANTIBIOTICS FOR USE IN THE PEDIATRIC POPULATION FOR THE TREATMENT OF SERIOUS BACTERIAL INFECTIONS WHERE MULTIDRUG-RESISTANT ORGANISMS ARE COMMON, AND 2) DEVELOP ANTIBIOTICS FOR USE IN PUBLIC HEALTH AND BIOTHREAT EMERGEN
Business Details
- UEI
- H8K6F2A4KD49
- CAGE Code
- 7XFT1
- Address
- 44 WHIPPANY RD STE 280
MORRISTOWN, NJ 079604558 - Congressional District
- NJ-11
- Phone
- 9086171336
Parent Company
MELINTA THERAPEUTICS, LLC
Data Source
This profile is based on federal contract award data from USAspending.gov.
View on USAspending.gov